Chemours (CC) PT Lowered to $43 at RBC Capital
Tweet
Share
E-mail
Get Alerts CC Hot Sheet
Price: $15.64 +3.58%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $43.00 (from $50.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- Dell (DELL) PT Raised to $500; TD Cowen: 'Phenomenal Results & Guidance'
- GitLab Inc (GTLB) PT Raised to $55 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
